# Microbiome Molecular Charaterisation

> **NCT06423976** · — · RECRUITING · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 1000 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Sequencing study

## Key facts

- **NCT ID:** NCT06423976
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-23
- **Primary completion:** 2038-10
- **Final completion:** 2038-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423976, "Microbiome Molecular Charaterisation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06423976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*